Najat Khan Recursion Pharmaceuticals has poached Najat Khan from Johnson & Johnson, where she led AI efforts at one of healthcare’s giants.
Khan will serve as chief R&D and commercial officer, along with joining Recursion’s board. The move comes at a…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
For all the high-flying claims for AI in drug discovery, Leash Bio has started with a more grounded approach — literally. Leash’s lab and headquarters were in the basement of Ian Quigley’s Utah home for […]
SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ — Utah-based Second Heart Assist Inc., has completed the third in a planned series of studies at a leading clinical site in Asuncion, Paraguay, for use of mechanical […]
BenevolentAI’s CEO Joerg Moeller is stepping down effective immediately, the London biotech said Thursday, in the latest leadership shakeup atop the company. Since going public in early 2022 via a SPAC, BenevolentAI’s stock price has […]
Copyright © 2026 Biotech Networks
